Novartis Delays Restarting Of Lincoln Facility

By: The Associated Press Email
By: The Associated Press Email

Swiss pharmaceutical company Novartis says it is not yet ready to resume production at its facility in Lincoln.

The plant is unlikely to ship over-the-counter drugs before year's end. The company said in a statement Thursday that restarting production is taking longer than expected.

At least one over-the-counter product, Excedrin, started hitting shelves again within the past week, but the company says it is being manufactured at third-party sites.

Novartis shut down the Lincoln plant last December after federal inspections found numerous quality-control problems. Excedrin is one of many products from the Lincoln plant that have been out of stock since the plant shut down. Others include Bufferin, NoDoz, Gas-X, Triaminic, Lamisil and Theraflu.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WOWT NBC Omaha 3501 Farnam Street Omaha, NE 68131 (402) 346-6666 sixonline@wowt.com
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 175870311